Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Pain Management: Optimizing the Care of Patients with Comorbid Behavioral Health Conditions
Track:
Pre-Meeting Workshops (CE)
Program Code: 294-L01
Date: Sunday, December 6, 2009
Time: 8:30 AM to 4:30 PM EST
Location:
Titian 2302
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Jennifer Strickland, PharmD, BCPS, Co-Director of Center for Advancing QOL (LRMC), Lakeland Regional Medical Center - Department of Pharmacy
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Dr. Ernest Dole, BS Pharm, PharmD, Pharmaceutical Care Coordinator, ABQ Health Partners
Dr. Christopher Herndon, PharmD, BCPS, Assistant Professor, Southern Illinois University - Edwardsville
Dr. Angela Huskey, PharmD, CPE, Medical Science Liaison, Adolor Corporation
Mary Lynn McPherson, PharmD, BCPS, Professor, Vice Chair, and Hospice Consultant Pharmacist, University of Maryland School of Pharmacy Jennifer Strickland, PharmD, BCPS, Co-Director of Center for Advancing QOL (LRMC), Lakeland Regional Medical Center - Department of Pharmacy
Description
ACPE Activity #204-000-09-294-L01
7.0 Contact Hours / Application-based
Pre-registration required; onsite registration not available.
Faculty: David Craig, PharmD, BCPS, Pain and Palliative Care Specialist, H. Lee Moffitt Cancer Center, Tampa, FL; Ernest J. Dole, BS Pharm, PharmD, FASHP, Pharmaceutical Care Coordinator, ABQ Health Partners, Albuquerque, NM; Christopher Herndon, PharmD, BCPS, Assistant Professor, Southern Illinois University - Edwardsville; Angela Huskey, PharmD, CPE, Medical Science Liaison, Adolor Corporation, Tampa, FL; Ben Klein, PhD, Psychologist, ABQ Health Partners, Albuquerque, NM; Mary Lynn McPherson, PharmD, BCPS, FASHP, Professor and Vice Chair, University of Maryland School of Pharmacy, Baltimore; and Hospice Consultant Pharmacist; and Jennifer Strickland, PharmD, BCPS, Co-Director, Center for Advancing QOL (LMRC); Pain Specialist; and Director of Pharmacy, Lakeland Regional Medical Center,Lakeland, FL
Learning Objectives:
7.0 Contact Hours / Application-based
Pre-registration required; onsite registration not available.
Faculty: David Craig, PharmD, BCPS, Pain and Palliative Care Specialist, H. Lee Moffitt Cancer Center, Tampa, FL; Ernest J. Dole, BS Pharm, PharmD, FASHP, Pharmaceutical Care Coordinator, ABQ Health Partners, Albuquerque, NM; Christopher Herndon, PharmD, BCPS, Assistant Professor, Southern Illinois University - Edwardsville; Angela Huskey, PharmD, CPE, Medical Science Liaison, Adolor Corporation, Tampa, FL; Ben Klein, PhD, Psychologist, ABQ Health Partners, Albuquerque, NM; Mary Lynn McPherson, PharmD, BCPS, FASHP, Professor and Vice Chair, University of Maryland School of Pharmacy, Baltimore; and Hospice Consultant Pharmacist; and Jennifer Strickland, PharmD, BCPS, Co-Director, Center for Advancing QOL (LMRC); Pain Specialist; and Director of Pharmacy, Lakeland Regional Medical Center,Lakeland, FL
Learning Objectives:
- Assess patients to identify presence of risk factors for opioid or controlled substance misuse.
- Design a treatment regimen intended to optimize outcomes while managing risk, including substance abuse risk, and incorporate available treatment tools into the plan (e.g., treatment agreements, urine drug screens, psychiatric care).
- Identify comorbid conditions that complicate the management of pain and other symptoms in the pain and palliative care population, including psychiatric illness and substance abuse.
- Identify strategies to manage risk associated with opioid or controlled substance therapy, including assessment tools, urine drug screening, and treatment modification.
Handout Online
